CrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity ...
SANTA CLARA, Calif., July 06, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to …